Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
EUTECTIC OF TELMISARTAN AND HYDROCHLOROTHIAZIDE
Document Type and Number:
WIPO Patent Application WO/2019/033969
Kind Code:
A1
Abstract:
Disclosed are a eutectic of telmisartan and hydrochlorothiazide, a preparation method therefor and the use thereof. In the eutectic, the molar ratio of telmisartan to hydrochlorothiazide is 1:1. The eutectic of telmisartan and hydrochlorothiazide is fully characterized by X-ray single crystal diffraction analysis, H nuclear magnetic resonance spectroscopy, thermogravimetric analysis, differential scanning calorimetry, infrared spectrum analysis and other means, and it is found that the maximum blood concentration of the eutectic in SD rats is higher than that of both hydrochlorothiazide and telmisartan. The eutectic of telmisartan and hydrochlorothiazide has a simple preparation method and good physical and chemical properties.

Inventors:
MEI XUEFENG (CN)
WANG JIANRONG (CN)
YU QIHUI (CN)
Application Number:
PCT/CN2018/099349
Publication Date:
February 21, 2019
Filing Date:
August 08, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI INST MATERIA MEDICA CAS (CN)
International Classes:
A61K31/4184; C07D235/18; A61K31/549; A61P9/00; A61P9/04; A61P9/12; C07D285/28; C07D285/32
Domestic Patent References:
WO2011025467A12011-03-03
WO2011147026A22011-12-01
Foreign References:
CN107501192A2017-12-22
CN1780618A2006-05-31
CN102512423A2012-06-27
CN101080225A2007-11-28
CN106562973A2017-04-19
Attorney, Agent or Firm:
KINGSOUND & PARTNERS (CN)
Download PDF: